MGTX
Meiragtx Holdings Plc
NASDAQ · Biotechnology
$7.43
+0.23 (+3.19%)
Open$7.34
Previous Close$7.20
Day High$7.57
Day Low$7.22
52W High$9.73
52W Low$4.55
Volume—
Avg Volume387.3K
Market Cap598.05M
P/E Ratio—
EPS$-2.11
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+748.0% upside
Current
$7.43
$7.43
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 38.36M | 39.99M | 317.19M |
| Net Income | -170,375,063 | -159,843,173 | -41,054,821 |
| Profit Margin | -444.1% | -421.9% | -12.9% |
| EBITDA | -156,417,943 | -154,901,538 | -45,049,439 |
| Free Cash Flow | — | — | -29,515,122 |
| Rev Growth | -4.1% | -4.1% | +21.7% |
| Debt/Equity | 1.08 | 1.08 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |